Morgan Stanley’s Nektar Therapeutics NKTR Stock Holding History

Morgan Stanley’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47.4M	Buy	659,387 +92,966	+16%	+$5.29M	﹤0.01%	2150
2025 Q4	$23.9M	Sell	566,421 -362,730	-39%	-$20.3M	﹤0.01%	2763
2025 Q3	$52.9M	Buy	929,151 +857,012	+1,188%	+$28.4M	﹤0.01%	1958
2025 Q2	$1.86M	Buy	72,139 +33,198	+85%	+$373K	﹤0.01%	4745
2025 Q1	$397K	Sell	38,941 -14,548	-27%	-$190K	﹤0.01%	5433
2024 Q4	$746K	Buy	53,489 +3,748	+8%	+$66.1K	﹤0.01%	5236
2024 Q3	$970K	Sell	49,741 -48,434	-49%	-$923K	﹤0.01%	5060
2024 Q2	$1.83M	Buy	98,175 +86,922	+772%	+$1.83M	﹤0.01%	4623
2024 Q1	$158K	Sell	11,253 -61,780	-85%	-$647K	﹤0.01%	5809
2023 Q4	$619K	Buy	73,033 +16,358	+29%	+$124K	﹤0.01%	5535
2023 Q3	$506K	Sell	56,675 -48,233	-46%	-$464K	﹤0.01%	5164
2023 Q2	$905K	Sell	104,908 -18,254	-15%	-$195K	﹤0.01%	4891
2023 Q1	$1.3M	Buy	123,162 +13,613	+12%	+$412K	﹤0.01%	4715
2022 Q4	$3.71M	Sell	109,549 -43,975	-29%	-$2.13M	﹤0.01%	4002
2022 Q3	$7.37M	Buy	153,524 +840	+0.6%	+$50K	﹤0.01%	3291
2022 Q2	$8.7M	Buy	152,684 +40,495	+36%	+$2.56M	﹤0.01%	3207
2022 Q1	$9.07M	Buy	112,189 +12,165	+12%	+$1.8M	﹤0.01%	3014
2021 Q4	$20.3M	Buy	100,024 +42,300	+73%	+$9.18M	﹤0.01%	2125
2021 Q3	$15.6M	Buy	57,724 +25,923	+82%	+$6.23M	﹤0.01%	2369
2021 Q2	$8.19M	Sell	31,801 -2,808	-8%	-$777K	﹤0.01%	3226
2021 Q1	$10.4M	Buy	34,609 +3,697	+12%	+$1.15M	﹤0.01%	2608
2020 Q4	$7.88M	Buy	30,912 +3,955	+15%	+$1.02M	﹤0.01%	2767
2020 Q3	$6.71M	Buy	26,957 +1,284	+5%	+$404K	﹤0.01%	2423
2020 Q2	$8.92M	Sell	25,673 -19,778	-44%	-$6.17M	﹤0.01%	2069
2020 Q1	$12.2M	Buy	45,451 +6,945	+18%	+$2.15M	﹤0.01%	1634
2019 Q4	$12.5M	Buy	38,506 +4,867	+14%	+$1.41M	﹤0.01%	2157
2019 Q3	$9.19M	Buy	33,639 +3,265	+11%	+$1.2M	﹤0.01%	2225
2019 Q2	$16.2M	Sell	30,374 -24,604	-45%	-$12.3M	﹤0.01%	1668
2019 Q1	$27.7M	Sell	54,978 -38,283	-41%	-$22.7M	0.01%	1206
2018 Q4	$46M	Buy	93,261 +7,278	+8%	+$4.39M	0.01%	855
2018 Q3	$78.6M	Buy	85,983 +5,795	+7%	+$4.95M	0.02%	719
2018 Q2	$58.7M	Sell	80,188 -4,978	-6%	-$5.74M	0.02%	830
2018 Q1	$136M	Buy	85,166 +35,209	+70%	+$45.4M	0.04%	458
2017 Q4	$44.8M	Buy	49,957 +3,087	+7%	+$1.83M	0.01%	1021
2017 Q3	$16.9M	Buy	46,870 +2,713	+6%	+$849K	0.01%	1735
2017 Q2	$12.9M	Buy	44,157 +4,623	+12%	+$1.34M	﹤0.01%	1925
2017 Q1	$13.9M	Sell	39,534 -31,064	-44%	-$6.98M	﹤0.01%	1894
2016 Q4	$13M	Buy	70,598 +30,899	+78%	+$6.28M	﹤0.01%	1979
2016 Q3	$10.2M	Buy	39,699 +7,701	+24%	+$1.98M	﹤0.01%	1988
2016 Q2	$6.83M	Sell	31,998 -1,916	-6%	-$428K	﹤0.01%	2320
2016 Q1	$7M	Buy	33,914 +1,569	+5%	+$301K	﹤0.01%	2190
2015 Q4	$8.18M	Sell	32,345 -1,488	-4%	-$306K	﹤0.01%	2182
2015 Q3	$5.56M	Sell	33,833 -1,728	-5%	-$306K	﹤0.01%	2558
2015 Q2	$6.67M	Sell	35,561 -1,535	-4%	-$264K	﹤0.01%	2533
2015 Q1	$6.12M	Buy	37,096 +290	+0.8%	+$59.6K	﹤0.01%	2560
2014 Q4	$8.56M	Sell	36,806 -356	-1%	-$76.1K	﹤0.01%	2208
2014 Q3	$6.73M	Sell	37,162 -4,797	-11%	-$918K	﹤0.01%	2374
2014 Q2	$8.07M	Sell	41,959 -1,861	-4%	-$329K	﹤0.01%	2222
2014 Q1	$7.97M	Sell	43,820 -7,423	-14%	-$1.47M	﹤0.01%	2143
2013 Q4	$8.72M	Buy	51,243 +13,491	+36%	+$2.18M	﹤0.01%	2065
2013 Q3	$5.92M	Buy	37,752 +6,204	+20%	+$1.15M	﹤0.01%	2251
2013 Q2	$5.47M	Buy	+31,548	New	+$4.84M	﹤0.01%	2241

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return